4-Step Renal Dosimetry Dependent on Cortex Geometry Applied to 90Y Peptide Receptor Radiotherapy: Evaluation Using a Fillable Kidney Phantom Imaged by 90Y PET
Authors:
- Stephan WalrandSWStephan Walrand
- François JamarFJFrançois Jamar
- Larry van ElmbtLELarry van Elmbt
- Renaud LhommelRLRenaud Lhommel
- Edgar Bidja'A BekondeEBEdgar Bidja'A Bekonde
- Stanislas PauwelsSPStanislas Pauwels
Open Access
- 15 November 2010
- journal article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 51 (12) , 1969-1973
Abstract
Accurate dosimetry in 90Y peptide receptor radionuclide therapy (PRRT) helps to optimize the injected activity, to prevent kidney or red marrow toxicity, while giving the highest absorbed dose to tumors. The aim of this study was to evaluate whether direct 90Y bismuth germanate or lutetium yttrium orthosilicate time-of-flight PET was accurate enough to provide dosimetry estimates suitable to 90Y PRRT. Method: To overcome the statistical uncertainty arising from the low 90Y positron counting rate, the computation of the cortex mean-absorbed dose was divided into 4 steps: delineation of the cortex volume of interest (VOI) on the CT scan, determination of the recovery coefficient from the cortex VOI using the point-spread function of the whole imaging process, determination of the mean cortex-absorbed dose per unit cumulated activity in the cortex (Scortex←cortex value) from the cortex VOI using a 90Y voxel S value kernel, and determination of the number of decays in the cortex VOI from the PET reconstruction. Our 4-step method was evaluated using an anthropomorphic abdominal phantom containing a fillable kidney phantom based on the MIRD kidney model. Vertebrae with an attenuation similar to that of bone were also modeled. Two tumors were modeled by 7-mL hollow acrylic spheres and the spleen by a plastic bag. Activities corresponded to typical tissue uptake in a first 90Y-DOTATOC cycle of 4.4 GBq, considered as free of significant renal toxicity. Eight successive 45-min scans were acquired on both systems. Results: Both PET systems were successful in determining absorbed dose to modeled tumors but failed to provide accurate red marrow dosimetry. Renal cortex dosimetry was reproducible for both PET systems, with an accuracy of 3% for the bismuth germanate system but only 18% for the lutetium yttrium orthosilicate time-of-flight system, which was hindered by the natural radioactivity of the crystal, especially in the most attenuated area of the kidney. Conclusion: This study supports the use of direct 90Y PET of the first PRRT cycle to assess the kidney-absorbed dose and optimize the injected activity of the following cycles.Keywords
This publication has 15 references indexed in Scilit:
- MIRD Pamphlet No. 20: The Effect of Model Assumptions on Kidney Dosimetry and Response—Implications for Radionuclide TherapyJournal of Nuclear Medicine, 2008
- State of the Art in Nuclear Medicine Dose AssessmentSeminars in Nuclear Medicine, 2008
- Evaluation of quantitative90Y SPECT based on experimental phantom studiesPhysics in Medicine & Biology, 2008
- Three-Dimensional Imaging-Based Radiobiological DosimetrySeminars in Nuclear Medicine, 2008
- Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray”European Journal of Nuclear Medicine and Molecular Imaging, 2007
- Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray”European Journal of Nuclear Medicine and Molecular Imaging, 2007
- Clinical applications of newer radionuclide therapiesEuropean Journal of Cancer, 2006
- The Impact of PET and SPECT on Dosimetry for Targeted Radionuclide TherapyZeitschrift für Medizinische Physik, 2006
- Quantitation in PET using isotopes emitting prompt single gammas: application to yttrium-86European Journal of Nuclear Medicine and Molecular Imaging, 2002
- Yttrium‐90 biodistribution by yttrium‐87 imaging: A theoretical feasibility analysisMedical Physics, 1998